ArticleNPJ precision oncology2022

HER3 activation contributes toward the emergence of ALK inhibitor-tolerant cells in ALK-rearranged lung cancer with mesenchymal features.

Keiko Tanimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.